A detailed history of Fmr LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Fmr LLC holds 21,894,806 shares of IONS stock, worth $849 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
21,894,806
Previous 21,862,735 0.15%
Holding current value
$849 Million
Previous $948 Million 10.1%
% of portfolio
0.07%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$36.45 - $47.7 $1.17 Million - $1.53 Million
32,071 Added 0.15%
21,894,806 $1.04 Billion
Q1 2024

May 13, 2024

BUY
$42.03 - $53.55 $14.4 Million - $18.3 Million
341,863 Added 1.59%
21,862,735 $948 Million
Q4 2023

Feb 13, 2024

BUY
$43.39 - $51.63 $952,410 - $1.13 Million
21,950 Added 0.1%
21,520,872 $1.09 Billion
Q3 2023

Nov 13, 2023

BUY
$38.5 - $47.13 $1.35 Million - $1.65 Million
35,106 Added 0.16%
21,498,922 $975 Million
Q2 2023

Aug 11, 2023

BUY
$34.73 - $43.33 $954,449 - $1.19 Million
27,482 Added 0.13%
21,463,816 $881 Million
Q1 2023

May 11, 2023

BUY
$33.58 - $41.2 $4.33 Million - $5.31 Million
128,815 Added 0.6%
21,436,334 $766 Million
Q4 2022

Feb 13, 2023

BUY
$37.12 - $46.52 $607,283 - $761,067
16,360 Added 0.08%
21,307,519 $805 Million
Q3 2022

Nov 10, 2022

BUY
$36.54 - $48.66 $789,227 - $1.05 Million
21,599 Added 0.1%
21,291,159 $942 Million
Q2 2022

Aug 12, 2022

SELL
$31.71 - $43.0 $1.63 Million - $2.21 Million
-51,326 Reduced 0.24%
21,269,560 $787 Million
Q1 2022

May 13, 2022

BUY
$29.88 - $37.04 $4.16 Million - $5.16 Million
139,384 Added 0.66%
21,320,886 $790 Million
Q4 2021

Feb 14, 2022

BUY
$25.61 - $35.1 $239,402 - $328,114
9,348 Added 0.04%
21,181,502 $645 Million
Q3 2021

Nov 15, 2021

BUY
$33.54 - $40.55 $929,024 - $1.12 Million
27,699 Added 0.13%
21,172,154 $710 Million
Q2 2021

Aug 13, 2021

BUY
$34.54 - $47.25 $730 Million - $999 Million
21,144,455 New
21,144,455 $843 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.5B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.